A Single-Arm, Open-Label, Phase 1 Study to Determinethe Safety, Tolerability and Preliminary Efficacy of Obecabtagene Autoleucel in Patients with Severe, Refractory SystemicLupus Erythematosus.
Datos básicos
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
AUTOLUS LIMITED
Portal de investigación